Actual patients. Results may vary.
Photos taken at full smile before and after treatment with BOTOX® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30.1 In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.2
Photos taken at maximum frown before and after treatment with BOTOX® Cosmetic (onabotulinumtoxinA) at day 7. In clinical studies, physicians assessed 80% of people had significant improvement at day 30.1 Photos taken at maximum frown and/or full smile before and after treatment with BOTOX® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies for moderate to severe crow’s feet, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30.1 In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.2 In clinical studies for moderate to severe frown lines, physicians assessed 80% of people had significant improvement at day 30.1
Side effects associated with the injection include localized pain, infection, inflammation, tenderness, swelling, redness, and/or bleeding/bruising.1
Photos taken at full smile before and after treatment with BOTOX® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30.1 In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.2
Photos taken at maximum frown before and after treatment with BOTOX® Cosmetic (onabotulinumtoxinA) at day 7. In clinical studies, physicians assessed 80% of people had significant improvement at day 30.1 Photos taken at maximum frown and/or full smile before and after treatment with BOTOX® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies for moderate to severe crow’s feet, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30.1 In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.2 In clinical studies for moderate to severe frown lines, physicians assessed 80% of people had significant improvement at day 30.1
Side effects associated with the injection include localized pain, infection, inflammation, tenderness, swelling, redness, and/or bleeding/bruising.1